Strategy Asset Managers’s AbbVie ABBV Stock Holding History

Strategy Asset Managers’s Portfolio ABBV Stock Details ABBV Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$343K	Buy	1,846 +290	+19%	+$53.8K	0.06%	184
2025 Q1	$326K	Buy	1,556 +18	+1%	+$3.77K	0.07%	199
2024 Q4	$273K	Sell	1,538 -105	-6%	-$18.7K	0.05%	218
2024 Q3	$324K	Buy	+1,643	New	+$324K	0.06%	206
2023 Q2	–	Sell	-1,885	Closed	-$300K	–	243
2023 Q1	$300K	Sell	1,885 -39	-2%	-$6.22K	0.07%	173
2022 Q4	$311K	Sell	1,924 -98	-5%	-$15.8K	0.08%	175
2022 Q3	$271K	Buy	+2,022	New	+$271K	0.07%	185
2019 Q3	–	Sell	-5,582	Closed	-$406K	–	120
2019 Q2	$406K	Sell	5,582 -952	-15%	-$69.2K	0.12%	106
2019 Q1	$527K	Sell	6,534 -9,507	-59%	-$767K	0.12%	103
2018 Q4	$1.48M	Sell	16,041 -2,089	-12%	-$193K	0.36%	67
2018 Q3	$1.71M	Sell	18,130 -29,605	-62%	-$2.8M	0.35%	85
2018 Q2	$4.42M	Sell	47,735 -2,015	-4%	-$187K	0.93%	35
2018 Q1	$4.71M	Buy	49,750 +26,367	+113%	+$2.5M	1.02%	32
2017 Q4	$2.26M	Sell	23,383 -1,051	-4%	-$102K	0.44%	75
2017 Q3	$2.17M	Sell	24,434 -153	-0.6%	-$13.6K	0.44%	77
2017 Q2	$1.78M	Buy	24,587 +8,266	+51%	+$599K	0.37%	85
2017 Q1	$1.06M	Buy	16,321 +1	+0%	+$65	0.23%	85
2016 Q4	$986K	Buy	16,320 +26	+0.2%	+$1.57K	0.22%	83
2016 Q3	$1.03M	Buy	16,294 +1,556	+11%	+$98.2K	0.23%	87
2016 Q2	$912K	Buy	14,738 +553	+4%	+$34.2K	0.21%	93
2016 Q1	$810K	Buy	14,185 +1,109	+8%	+$63.3K	0.18%	96
2015 Q4	$775K	Buy	13,076 +19	+0.1%	+$1.13K	0.18%	91
2015 Q3	$710K	Sell	13,057 -87	-0.7%	-$4.73K	0.17%	92
2015 Q2	$883K	Buy	13,144 +380	+3%	+$25.5K	0.2%	86
2015 Q1	$747K	Sell	12,764 -154	-1%	-$9.01K	0.16%	89
2014 Q4	$845K	Buy	12,918 +221	+2%	+$14.5K	0.18%	86
2014 Q3	$733K	Sell	12,697 -553	-4%	-$31.9K	0.16%	87
2014 Q2	$748K	Sell	13,250 -154	-1%	-$8.69K	0.16%	79
2014 Q1	$689K	Sell	13,404 -213	-2%	-$10.9K	0.15%	84
2013 Q4	$719K	Buy	13,617 +1,629	+14%	+$86K	0.16%	82
2013 Q3	$536K	Sell	11,988 -145	-1%	-$6.48K	0.13%	87
2013 Q2	$502K	Buy	+12,133	New	+$502K	0.12%	89